
|Articles|October 1, 2001
Hydroflex II acrylic IOL
The FDA has approved phase I clinicaltrials on Medical Developmental Research Inc.'s Hydroflex II Advanced SeriesHydrophilic Acrylic IOL.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement




























